Published in J Neurol Neurosurg Psychiatry on October 01, 2005
Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One (2010) 1.72
Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease. Neuroscience (2011) 1.05
Mirror writing: neurological reflections on an unusual phenomenon. J Neurol Neurosurg Psychiatry (2006) 1.03
Mirror movements in patients with essential tremor. Mov Disord (2009) 0.95
Mirror movements in neurology. J Neurol Neurosurg Psychiatry (2005) 0.94
Mirror movements in movement disorders: a review. Tremor Other Hyperkinet Mov (N Y) (2012) 0.93
Inter-hemispheric inhibition is impaired in mirror dystonia. Eur J Neurosci (2009) 0.91
Role of the right dorsal premotor cortex in "physiological" mirror EMG activity. Exp Brain Res (2006) 0.89
Mirror movements. Ann Indian Acad Neurol (2012) 0.89
Mirror movements in Parkinson's disease: effect of dopaminergic drugs. J Neurol Neurosurg Psychiatry (2006) 0.83
A functional magnetic resonance imaging study of pathophysiological changes responsible for mirror movements in Parkinson's disease. PLoS One (2013) 0.80
Ipsilateral synkinesia involves the supplementary motor area. Neurosci Lett (2012) 0.77
Mirror movements in essential tremor: prevalence and relationship to mini-mental status test scores. Tremor Other Hyperkinet Mov (N Y) (2012) 0.77
The Clinical Evaluation of Parkinson's Tremor. J Parkinsons Dis (2015) 0.77
The dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD). J Neurol (2014) 0.76
Deep brain stimulation for early-stage Parkinson's disease: an illustrative case. Neuromodulation (2011) 0.76
Congenital Mirror Movements Due to RAD51: Cosegregation with a Nonsense Mutation in a Norwegian Pedigree and Review of the Literature. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75
Through the looking glass: persistent mirror movements. CMAJ (2007) 0.75
Excessive motor overflow reveals abnormal inter-hemispheric connectivity in Friedreich ataxia. J Neurol (2013) 0.75
Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson's Disease: Longitudinal Data from the Jönköping Parkinson Registry. Parkinsons Dis (2017) 0.75
Mirror movements studied in a patient with Klippel-Feil syndrome. J Physiol (1990) 1.86
Alien hand phenomena: a review with the addition of six personal cases. Can J Neurol Sci (2000) 1.80
Reorganization of motor output in the non-affected hemisphere after stroke. Brain (1997) 1.65
Intracranial complications following transorbital penetrating injuries. Br J Surg (1969) 1.62
Congenital mirror movements. J Neurol Neurosurg Psychiatry (1981) 1.34
Quantitative assessment of mirror movements after stroke. Stroke (1998) 1.33
Neuromotor development from 5 to 18 years. Part 2: associated movements. Dev Med Child Neurol (2001) 1.30
Interhemispheric control of manual motor activity. Behav Brain Res (1994) 1.22
Bilateral primary sensori-motor cortex activation of post-stroke mirror movements: an fMRI study. Neuroreport (2003) 1.17
Role of the ipsilateral motor cortex in mirror movements. J Neurol Neurosurg Psychiatry (1997) 1.16
Large mirror movements of upper extremities in Williams syndrome. Pediatr Neurol (1994) 1.15
Klippel-Feil syndrome, iniencephalus, anencephalus, hindbrain hernia and mirror movements: overdistention of the neural tube. Childs Brain (1979) 1.09
Effort-induced mirror movements. A study of transcallosal inhibition in humans. Exp Brain Res (2002) 1.07
Kallmann's syndrome: mirror movements associated with bilateral corticospinal tract hypertrophy. Neurology (1999) 1.05
Management of orbital-cranial trauma. Adv Ophthalmic Plast Reconstr Surg (1987) 0.99
Mirror movements of the non-affected hand in hemiparkinsonian patients: a reflection of ipsilateral motor overactivity? J Neurol Neurosurg Psychiatry (2003) 0.96
Mirror movements associated with cervical meningocele: case report. Minim Invasive Neurosurg (1998) 0.96
Cervical cord tethering and congenital mirror movements: is it an association rather than a coincidence? Br J Neurosurg (2002) 0.95
Cortico-muscular coupling in a human subject with mirror movements--a magnetoencephalographic study. Neurosci Lett (2002) 0.88
Mirror movements in hemiparesis. Confin Neurol (1974) 0.87
Ataxic hemiparesis and mirror movements. J Neurol Neurosurg Psychiatry (1981) 0.84
[Meningitis caused by orbital injuries]. Bull Soc Ophtalmol Fr (1976) 0.83
UMLS concept indexing for production databases: a feasibility study. J Am Med Inform Assoc (2001) 9.02
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Organization of heterogeneous scientific data using the EAV/CR representation. J Am Med Inform Assoc (1999) 6.97
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet (2001) 6.67
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 6.21
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage (2001) 4.48
GEM: a proposal for a more comprehensive guideline document model using XML. J Am Med Inform Assoc (2000) 4.46
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol (1999) 3.99
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2002) 2.81
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord (1994) 2.77
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology (2006) 2.70
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology (2003) 2.65
Primary structure of major outer membrane protein II (ompA protein) of Escherichia coli K-12. Proc Natl Acad Sci U S A (1980) 2.64
Primary structure of major outer membrane protein I of Escherichia coli B/r. Proc Natl Acad Sci U S A (1979) 2.60
The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60
The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg (2000) 2.56
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain (2012) 2.52
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52
Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain (1986) 2.52
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet (1995) 2.47
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain (2009) 2.35
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain (2000) 2.25
Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr (2001) 2.25
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods (2001) 2.22
Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol (1998) 2.21
Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA (2001) 2.20
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology (1998) 2.19
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes Obes Metab (2009) 2.19
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology (2012) 2.14
Simultaneous bilateral laser in situ keratomileusis: safety and efficacy. Ophthalmology (1999) 2.13
The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med (1996) 2.11
Arm levitation in progressive supranuclear palsy. Neurology (1999) 2.06
The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06
Complete amino acid sequence and glycosylation sites of glycoprotein gp71A of Friend murine leukemia virus. Proc Natl Acad Sci U S A (1982) 2.06
Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest (1986) 2.05
Cortical-basal ganglionic degeneration. Neurology (1990) 2.04
Variation in river water temperatures in an upland stream over a 30-year period. Sci Total Environ (2001) 2.03
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer (2002) 2.03
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02
Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization. Am J Med (1987) 2.00
DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res (2000) 1.97
Radioimmunological screening method for specific membrane proteins. Anal Biochem (1979) 1.96
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Interactions between two different inhibitory systems in the human motor cortex. J Physiol (2001) 1.91
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology (1982) 1.88
An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet (1997) 1.88
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A (1995) 1.86
A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods (2001) 1.86
Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med (1997) 1.85
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology (1993) 1.83
TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene (2010) 1.81
Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology (2010) 1.79
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA (1997) 1.78
The 'essentials' of essential palatal tremor: a reappraisal of the nosology. Brain (2005) 1.78
MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics (1997) 1.77
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation (1995) 1.73
Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology (2006) 1.72
Complications of laparoscopic procedures after concentrated training in urological laparoscopy. J Urol (2001) 1.71
Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord (1997) 1.69
Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther (1999) 1.67
Dextromethorphan decreases the excitability of the human motor cortex. Neurology (1998) 1.66
Movement disorders in alcoholism: a review. Neurology (1990) 1.65
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett (1999) 1.62
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Curr Med Res Opin (2009) 1.62
A clone-array pooled shotgun strategy for sequencing large genomes. Genome Res (2001) 1.60
Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60
Involvement of the human subthalamic nucleus in movement preparation. Neurology (2003) 1.59
Transcranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology (2002) 1.59
Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun (2001) 1.58
Procedural learning and neostriatal dysfunction in man. Brain (1988) 1.57
LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology (2005) 1.56
The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol (2001) 1.54
Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli K12. Eur J Biochem (1987) 1.53
Antibacterial agents that inhibit two-component signal transduction systems. Proc Natl Acad Sci U S A (1998) 1.53
Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension (1995) 1.53
Timed voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev (2004) 1.53
The primary structure of protein L16 located at the peptidyltransferase center of Escherichia coli ribosomes. FEBS Lett (1976) 1.53
Inflammatory pseudotumor of the liver. Report of the fine needle aspiration cytologic findings in a case initially misdiagnosed as malignant. Acta Cytol (1989) 1.51
Root gravitropism: an experimental tool to investigate basic cellular and molecular processes underlying mechanosensing and signal transmission in plants. Annu Rev Plant Biol (2002) 1.51
Induction of microsatellite instability by oxidative DNA damage. Proc Natl Acad Sci U S A (1998) 1.51
- cross-linking sites in human and bovine fibrin. Biochemistry (1971) 1.50
Exposed water ice deposits on the surface of comet 9P/Tempel 1. Science (2006) 1.49
A single nuclease active site of the Escherichia coli RecBCD enzyme catalyzes single-stranded DNA degradation in both directions. J Biol Chem (2000) 1.49